Veracyte (VCYT) Asset Writedowns and Impairment (2012 - 2025)

Veracyte has reported Asset Writedowns and Impairment for 10 years, with the latest figure at $20.5 million in Q2 2025.

• Asset Writedowns and Impairment for Q2 2025 came in at $20.5 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2026 was $20.5 million (down 12.54% YoY), and the FY2025 annual result was $20.5 million, up 508.82% from the prior year.
• Asset Writedowns and Impairment advanced to $20.5 million in Q2 2025, from $2.8 million in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $34.9 million in Q3 2023 and troughed at $185000.0 in Q3 2024.
• A 4-year average of $11.9 million and a median of $3.0 million in 2022 frame the typical range for Asset Writedowns and Impairment.
• The largest YoY upside for Asset Writedowns and Impairment was 69.57% in 2024 against a maximum downside of 99.47% in 2024.
• A 4-year view of Asset Writedowns and Impairment shows it stood at $3.3 million in 2022, then surged by 865.61% to $32.0 million in 2023, then tumbled by 91.4% to $2.8 million in 2024, then jumped by 644.55% to $20.5 million in 2025.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $20.5 million in Q2 2025, $2.8 million in Q4 2024, and $185000.0 in Q3 2024.